Position in ANNX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$25,339,444
-$3,538,769 QoQ
Shares Held
4,437,731
-14.9% QoQ
Ownership
2.17%
of shares outstanding
% of Portfolio
1.51%
of 13F equity value
Holder Rank
#11
of 216 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bain Capital Life Sciences Investors, LLC holds $1,318,022,438 across 17 Biotechnology names. ANNX ranks #13 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KLRA |
Kailera Therapeutics, Inc.
|
22,583,268 | $497,509,394 | |
| 2 | NAMS |
NewAmsterdam Pharma Co N.V.
|
3,906,565 | $131,141,499 | |
| 3 | SVRA |
Savara Inc
|
17,600,621 | $108,419,825 | |
| 4 | SLDB |
Solid Biosciences Inc.
|
9,808,819 | $97,990,101 | |
| 5 | PHVS |
Pharvaris N.V.
|
2,675,509 | $92,519,101 | |
| 6 | OLMA |
Olema Pharmaceuticals, Inc.
|
7,085,249 | $88,636,464 | |
| 7 | COAG |
Hemab Therapeutics Holdings, Inc.
|
1,650,000 | $60,604,500 | |
| 8 | CABA |
Cabaletta Bio, Inc.
|
17,241,445 | $53,620,893 |
All Filings in ANNX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,339,444 | 4,437,731 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $28,878,213 | 5,212,674 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $26,350,326 | 5,249,069 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $16,009,660 | 5,249,069 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $12,597,765 | 5,249,069 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $10,130,703 | 5,249,069 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $26,927,723 | 5,249,069 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $50,022,508 | 8,449,748 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $41,401,119 | 8,449,208 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $62,402,431 | 8,703,268 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $36,600,204 | 8,061,719 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $13,456,545 | 5,701,926 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $20,070,779 | 5,701,926 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $18,813,471 | 4,886,616 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $25,263,804 | 4,886,616 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $22,259,902 | 3,601,926 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $12,220,937 | 3,241,628 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $8,849,644 | 3,241,628 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $37,246,305 | 3,241,628 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $60,326,697 | 3,241,628 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $72,969,046 | 3,241,628 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $90,246,923 | 3,241,628 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $81,137,948 | 3,241,628 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $97,994,414 | 3,241,628 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||